-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2025-05-27
FTCPX:NMF-FTCPX (USD)
MUTUAL FUND | Others |
Last Closing
USD 13.39Change
-0.01 (-0.07)%Market Cap
N/AVolume
N/AAnalyst Target
N/A
N/A
Verdict
Values as of: 2025-05-27
MUTUAL FUND | Others |
Last Closing
USD 13.39Change
-0.01 (-0.07)%Market Cap
N/AVolume
N/AAnalyst Target
N/AN/A
Verdict
Currency: USD
Country : USA
Symbol | Name | Price(Change) | Market Cap |
---|---|---|---|
VRGWX | Vanguard Russell 1000 Growth I.. |
+18.78 (+2.43%) |
USD 26.28B |
XMDYX | Mid Cap SPDR 400 Trust Series .. |
+11.60 (+2.13%) |
USD 19.32B |
VRTIX | Vanguard Russell 2000 Index Fu.. |
+7.77 (+2.48%) |
USD 10.02B |
VRVIX | Vanguard Russell 1000 Value In.. |
+5.16 (+1.62%) |
USD 9.85B |
VRNIX | Vanguard Scottsdale Funds - Va.. |
+10.49 (+2.06%) |
USD 7.05B |
VRTTX | Vanguard Russell 3000 Index Fu.. |
+10.27 (+2.07%) |
USD 3.51B |
XAODX | Alpine Total Dynamic Dividend .. |
+0.13 (+1.40%) |
USD 2.09B |
XNUVX | Nuveen Municipal Value Fd Inc |
+0.03 (+0.34%) |
USD 2.06B |
VRTGX | Vanguard Russell 2000 Growth I.. |
+8.96 (+2.41%) |
USD 1.19B |
XJPCX | Nuveen Preferred Income Opport.. |
+0.04 (+0.51%) |
USD 0.99B |
Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
---|---|---|---|---|---|
ZUT:CA | BMO Equal Weight Utilitie.. | 7.11 % | 0.60 % |
+0.25 (+0.94%) |
CAD 0.57B |
CIF:CA | iShares Global Infrastruc.. | 5.47 % | 0.72 % |
+0.35 (+0.94%) |
CAD 0.60B |
XUT:CA | iShares S&P/TSX Capped Ut.. | 5.43 % | 0.62 % |
+0.32 (+0.94%) |
CAD 0.35B |
MINF:CA | Middlefield Sustainable I.. | 4.58 % | 0.00 % |
+0.09 (+0.94%) |
CAD 0.02B |
FXM:CA | First Asset Morningstar C.. | 3.66 % | 0.67 % |
+0.18 (+0.94%) |
CAD 0.30B |
MCSM:CA | Manulife Multifactor Cana.. | 0.00 % | 0.68 % |
+0.73 (+0.94%) |
CAD 0.29B |
Market Performance vs. Industry/Classification (Others) | Market Performance vs. Exchange | ||||||
Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
YTD | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Trailing 12 Months | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Trailing 5 Years | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Average Annual (5 Year Horizon) | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Risk Return Profile | |||||||
Volatility (Standard Deviation) | N/A | N/A | N/A | N/A | N/A | ||
Risk Adjusted Return | N/A | N/A | N/A | N/A | N/A | ||
Market Capitalization | N/A | N/A | N/A | N/A | N/A |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
There is nothing we particularly like
There is nothing we particularly dislike